CB Scientific, Inc.

Equities

CBSC

US12506E1038

Market Closed - OTC Markets Other stock markets 14:44:49 2024-05-28 EDT			5-day change	1st Jan Change
0.07 ^USD	+4.48%		-12.50%	-36.36%

2022	CB Scientific, Inc. Announces FDA 510(k) Submission of Enhanced myCam Cardiac Event Monitor	CI
2022	CB Scientific, Inc. Appoints James Ott as Chief Technology Officer	CI

CB Scientific Inc Provides Revenue Guidance for the Year 2015

May 12, 2015 at 08:30 am

CB Scientific Inc. announced that it expects its proforma revenue to reach $2 million by the end of 2015 and expand exponentially thereafter.

Latest news about CB Scientific, Inc.

CB Scientific, Inc. Announces FDA 510(k) Submission of Enhanced myCam Cardiac Event Monitor	22-09-06	CI
CB Scientific, Inc. Appoints James Ott as Chief Technology Officer	22-05-03	CI
CB Scientific, Inc. Appoints Paul Danner as Chairman	21-10-28	CI
CB Scientific, Inc. Announces Appointment of Jeslie Chui as New Director for Asia Pacific	21-03-02	CI
CB Scientific, Inc. has signed a definitive agreement to acquire Cardiolink Corporation.	21-02-22	CI
CB Scientific. Inc. Announces Addition of Dozens of New Device Clinical Trials of my-Cam Device and New Hospital Monitoring Contracts Through Mango Wellness Co., Ltd. and My Cardia Thailand Co., Ltd	20-12-28	CI
CB Scientific, Inc. entered into an agreement to acquire Datrix, LLC for $2.1 million.	20-11-03	CI
CB Scientific, Inc. Announces the Launch of My-Cardia ECG Products and Services in Thailand	20-10-08	CI
CB Scientific, Inc. acquired Operating Business Assets of Prevent Health Care International Corp. from Prevent Health Care International Corp.	20-09-21	CI
Apotheca Biosciences, Inc. Agrees to Exclusive License Agreement with CB Scientific	19-06-27	CI
Apotheca Biosciences and CB Scientific Joint Venture to Market Hemp CBD Infused Energy & Chill Drinks Under Brands DAVA & Magic Dragon High	18-10-08	CI
FutureLand, Corp. acquired 20% stake in Apotheca Biosciences, Inc. from CB Scientific, Inc..	17-09-17	CI
CB Scientific, Inc. Develops three Core Platform Technologies; CannaRAPID, CannaNASAL, and CannaDERME, Focused on Precise Dosing and Controlled Release of Cannabinoid Compounds for Patients	17-06-21	CI
CB Scientific, Inc. Develops CannaRAPID, CannaNASAL and CannaDERME	17-05-15	CI
CB Scientific, Inc. Develops Cannabinoid Delivery Technologies: CannaRAPID(TM), CannaNASAL(TM) and CannaDERME(TM)	17-04-17	CI
CB Scientific, Inc. Elects Bobban Subhadra as Chief Operating Office and to the Board of Directors	17-03-13	CI
CB Scientific, Inc. acquired Marutronics LLC from Bobban Subhadra and Vijitha Vivekanandan for $15.7 million.	17-03-12	CI
CB Scientific Inc. will Change its Ticker to CBSC from NXAM.D	16-03-14	CI
Net X America Inc. will Change its Ticker to NXAMD from NXAM	16-02-16	CI
CB Scientific Inc. completed the acquisition of Net X America Inc. from Zig Lambo and others in a reverse merger transaction.	15-12-03	CI
CB Scientific Inc. signed a binding share purchase agreement and plan of transaction to acquire Net X America Inc. from Zig Lambo and others in a reverse merger transaction.	15-11-03	CI
CB Scientific Signs U.S. Distribution Agreement with Advanced Ethnobotanical Developments for Test4 Cannabis THC & CBD Detection Kits	15-08-10	CI
CB Scientific Inc Provides Revenue Guidance for the Year 2015	15-05-12	CI
FutureWorld To Sell CB Scientific	15-05-11	CI
CB Scientific Inc. Terminates Bill Short as the CEO; Plans to Move Offices to St. Petersburg, Southern Colorado and Northern California	15-03-30	CI

Chart CB Scientific, Inc.

Duration

Period

More charts

Company Profile

Sector

More about the company